Skip to main content
Equibles

Redmile Group, LLC

Position in AGMB — Agomab Therapeutics NV

CIK 1425738 Larkspur, CA
Back to AGMB Full portfolio

Position in AGMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,486,359
+$33,847,297 QoQ
Shares Held
2,733,926
+1649.7% QoQ
Ownership
5.55%
of shares outstanding
% of Portfolio
2.38%
of 13F equity value
Holder Rank
#3
of 34 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. AGMB ranks #12 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SRRK
Scholar Rock Holding Corp
 4,311,092 $237,110,060
2 KRYS
Krystal Biotech, Inc.
 632,005 $234,897,298
3 STOK
Stoke Therapeutics, Inc.
 3,945,920 $129,110,502
4 IMNM
Immunome Inc.
 4,911,590 $104,076,592
5 NRIX
Nurix Therapeutics, Inc.
 4,073,787 $98,830,072
6 ABSI
Absci Corp
 6,739,675 $78,112,833
7 ANNX
Annexon, Inc.
 11,869,877 $67,776,997
8 RGNX
REGENXBIO Inc.
 4,368,804 $52,338,271

All Filings in AGMB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,486,359 2,733,926
2026-03-31 $1,639,062 156,250